Evidence map›Paper›PMID 42577386›Full record

ArticleFrontiers in immunology2026

Environment shapes gut microbiome and determines susceptibility to DSS-colitis in

Tomoko Kumagai, Silke Rath, Shuangqi Fan, Farooq Z Rahman, Andrew M Smith

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomoko KumagaiDepartment of Gastroenterology, Whipps Cross University Hospital, Barts Health NHS Trust, London, United Kingdom.
Silke RathDepartment of Microbial Diseases, University College London (UCL) Eastman Dental Institute, University College London, London, United Kingdom.
Shuangqi FanCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Farooq Z RahmanDepartment of Microbial Diseases, University College London (UCL) Eastman Dental Institute, University College London, London, United Kingdom.
Andrew M SmithDepartment of Microbial Diseases, University College London (UCL) Eastman Dental Institute, University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory bowel disease (IBD) is characterized by marked clinical heterogeneity, reflecting complex interactions between host genetics, environmental exposures, and the gut microbiome. Although over 300 genetic risk loci have been identified, these account for only a fraction of disease variance, highlighting the importance of gene-environment interactions. ADAM-like Decysin-1 (ADAMDEC1) is a gastrointestinal-restricted metalloprotease implicated in mucosal repair and immune regulation, with reduced expression reported in IBD. While Methods: To dissect genetic and environmental contributions to colitis severity, C57BL/6J wild-type (WT) and Results: Environmental factors exerted a stronger influence than genotype on gut microbiome composition. WT mice displayed consistent inflammatory and transcriptional responses to DSS across environments, whereas Conclusion: These findings demonstrate that loss of

Indexed as

ADAM ProteinsColitisGastrointestinal MicrobiomeGene-Environment InteractionAnimalsDextran SulfateDisease Models, AnimalDisease SusceptibilityEnvironmentGenetic Predisposition to DiseaseMaleMiceMice, Inbred C57BLMice, KnockoutADAM ProteinsdecysinDextran SulfateADAMDEC1gene-environment interactionsgut microbiomemucosal inflammationphenotype variability

Identifiers

PMID42577386
PMCPMC13454422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.